Schulz Duggan
AI Supply-Chain Research, Optics/Memory/Macro, Original Asian/US Filings & Pricing
Aehr remains a concentrated, expensive way to own wafer-level photonics burn-in: its 10-K says silicon-photonics customers primarily drove that revenue growth, and FY2027 guidance of $130m-$150m could nearly triple FY2026 sales, yet shares value it at about 20x the guide. Teradyne's acquired photonic-chip test business is not material to its much larger sales; Aehr's top five customers provided 70% of FY2026 revenue, so orders matter more than the headline CPO opportunity. x.com
Aehr's latest order adds timing and scope but little scale, and the production ramp has slipped to calendar 2027. Its lead hyperscale customer is moving a second AI processor onto Sonoma burn-in, an order of about $6M versus a record $41M in April, when Aehr said the chip would reach production later this year. Sonoma can hold the chip's separate thermal zones at different temperatures. Teradyne just added burn-in to its Titan HP platform, and Aehr has yet to show revenue or set a report date. x.com
Aehr Test Systems is a case of narrative running ahead of the numbers. The bull case is reasonable: a young company with a strong position in silicon carbide burn-in, genuine hyperscaler interest in AI chip burn-in and room to expand into memory and logic. But the latest quarter showed revenue down 43% year over year, with no meaningful order conversion from the AI opportunities yet. Until revenue improves and orders come through more clearly, the story stays ahead of the fundamentals. x.com
Aehr Test Systems' valuation looks ahead of its fundamentals after a strong turnaround quarter. Q4 FY2026 revenue rose 33% to $18.8 million with a return to GAAP profit, bookings hit a record $60.7 million and effective backlog topped $100.6 million. FY2027 guidance of $130-150 million implies 160-200% growth, so the post-earnings run prices in high expectations that depend on shipping FOX-XP systems on schedule without margin erosion. TRT is preferred for now. x.com x.com
Aehr Test Systems stands to benefit as testing takes a larger share of expanding semiconductor capex. Teradyne CEO Greg Smith says test's share of semiconductor capex rose from 6.4% in 2025 to 8.1% in the first eight months of 2026, with conditions favorable for prolonged ATE growth. Data-center reliability is pushing testing upstream from systems toward packages and wafers, where Aehr dominates wafer-level burn-in. Aehr lacks a dedicated CPU segment. x.com
Keysight is the photonics test stock to buy now because the 1.6T production ramp, where the big checks get cashed, has not yet peaked and Keysight is the least exposed to a major correction. It reported $1.6B in revenue with 30% year-over-year growth projected for Q2, and is buying back $1.5B of stock because it sees the 1.6T cycle lasting through 2028. Its diversified $57B market cap makes it safer than Aehr, which has run too far too fast; Goldman has a $384 target. x.com
Aehr Test Systems is unattractive near $100, at 22.5x sales and 112x forward earnings, even though it will very likely go above $100. Other burn-in names such as AEM Holdings look better placed to play catch-up. x.com
Aehr Test Systems stands to benefit from Broadcom's custom AI chip ramp because these 600W–2kW multi-die packages need burn-in testing. Broadcom said XPU shipments rose 3.5x and laid out $115B of AI revenue in FY27 and $230B in FY28 with supply secured, backed by multi-gigawatt Google, Anthropic, OpenAI and Meta deployments. Aehr won a record $41M package-level burn-in order from its lead hyperscale customer for a custom AI ASIC, with a next-gen device moving to production later this year. x.com
Teradyne is a solid core position for the broader semiconductor test theme because it is much more diversified than a concentrated wafer-level burn-in bet such as Aehr Test Systems. x.com
Aehr Test Systems is key to AI manufacturing and can even be a bottleneck, but at almost 20x revenue through 2028 at the current price, it is stratospherically priced. The risk is giant if something goes wrong for the company or for the AI ramp, and even a slowdown could be deadly at such high valuations. Tech moats are not the same as financial moats. x.com
Aehr Test Systems is monetizing the test layer of the AI optical interconnect buildout as silicon photonics burn-in reaches production scale. It guided FY2027 revenue to $130-150M, up 160-200% from $50M, after record bookings of $60.7M and a $100.6M effective backlog. Every 800G and 1.6T transceiver and optical I/O chip in AI data centers needs reliability screening, so transceiver growth feeds burn-in demand. Its lead silicon photonics customer keeps reordering and a second is ramping. x.com
Advantest proved it deserves a premium valuation: its SoC tester market share rose from 56% in 2024 to 66% in 2025, widening its lead over Teradyne. It also received its first high-volume ATE order for silicon photonics. x.com
